Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001267336 | SCV001445517 | pathogenic | Inborn genetic diseases | 2017-12-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541631 | SCV003284022 | pathogenic | Exostoses, multiple, type 2 | 2022-06-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 986095). This premature translational stop signal has been observed in individual(s) with hereditary multiple osteochondromatosis (PMID: 32293802). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln391*) in the EXT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT2 are known to be pathogenic (PMID: 10679937, 19810120). |
Clinical Genetics and Genomics, |
RCV002541631 | SCV005013295 | pathogenic | Exostoses, multiple, type 2 | 2024-01-17 | criteria provided, single submitter | clinical testing |